GSK new HIV two-drug injection meets main goal in late-stage study
British drugmaker GlaxoSmithKline Plc said on Thursday its long-lasting
two-drug regimen to treat HIV met the main goal of a late-stage ...
|
View article...
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.
British drugmaker GlaxoSmithKline Plc said on Thursday its long-lasting
two-drug regimen to treat HIV met the main goal of a late-stage ...
|